Publicacións (67) Publicacións nas que participase algún/ha investigador/a

2021

  1. 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics

    Journal of Medicinal Chemistry, Vol. 64, Núm. 9, pp. 6310-6328

  2. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2677-2699

  3. A machine learning model for evaluating imported disease screening strategies in immigrant populations

    American Journal of Tropical Medicine and Hygiene, Vol. 105, Núm. 5, pp. 1413-1419

  4. Activity of imipenem, meropenem, cefepime, and sulbactam in combination with the β-lactamase inhibitor ln-1-255 against acinetobacter spp.

    Antibiotics, Vol. 10, Núm. 2, pp. 1-15

  5. Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 6, pp. 1498-1510

  6. An Improved Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Data Analysis Pipeline for the Identification of Carbapenemase-Producing Klebsiella pneumoniae

    Journal of clinical microbiology, Vol. 59, Núm. 7, pp. e0080021

  7. Application and perspectives of maldi–tof mass spectrometry in clinical microbiology laboratories

    Microorganisms, Vol. 9, Núm. 7

  8. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  9. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  10. Bioinformatics approaches to the study of antimicrobial resistance

    Revista Espanola de Quimioterapia, Vol. 34, pp. 15-17

  11. Blue light directly modulates the quorum network in the human pathogen Acinetobacter baumannii

    Scientific Reports, Vol. 11, Núm. 1

  12. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  13. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 445-450

  14. Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 639-650

  15. Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study

    Journal of Clinical Virology, Vol. 143

  16. Clones of enterotoxigenic and Shiga toxin-producing Escherichia coli implicated in swine enteric colibacillosis in Spain and rates of antibiotic resistance

    Veterinary Microbiology, Vol. 252

  17. Clínica diferencial en niños infectados por SARS-CoV-2, trazabilidad de contactos y rentabilidad de pruebas diagnósticas: estudio observacional transversal

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 94, Núm. 5, pp. 318-326

  18. Crispr-cas, a revolution in the treatment and study of eskape infections: Pre-clinical studies

    Antibiotics, Vol. 10, Núm. 7

  19. Detection, molecular characterization, and antimicrobial susceptibility, of Campylobacter spp. isolated from shellfish

    Microbial Risk Analysis, Vol. 18

  20. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3